These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6316430)

  • 1. Peripheral nerve damage following isolated extremity perfusion with cis-platinum.
    Busse O; Aigner K; Wilimzig H
    Recent Results Cancer Res; 1983; 86():264-7. PubMed ID: 6316430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of hyperthermic isolated limb perfusion with cisplatin for recurrent melanoma of the lower extremity after previous perfusion treatment.
    Hoekstra HJ; Schraffordt Koops H; de Vries LG; van Weerden TW; Oldhoff J
    Cancer; 1993 Aug; 72(4):1224-9. PubMed ID: 8393368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New modifications in isolated extremity perfusion ].
    Aigner K; Hild P; Hundeiker M
    Z Hautkr; 1982 Jul; 57(14):1044-54. PubMed ID: 6889794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal failure following hyperthermic isolation perfusion of the left leg.
    Rauschecker HF; Osterloh B
    Anticancer Res; 1987; 7(3 Pt B):451-3. PubMed ID: 3631905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular damage after hyperthermic isolated limb perfusion in patients with melanoma or sarcoma treated with chemotherapeutic agents.
    Bonifati DM; Ori C; Rossi CR; Caira S; Fanin M; Angelini C
    Cancer Chemother Pharmacol; 2000; 46(6):517-22. PubMed ID: 11138466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of isolated hyperthermic limb perfusion.
    Omlor G; Gross G; Ecker KW; Burger I; Feifel G
    World J Surg; 1992; 16(6):1117-9. PubMed ID: 1455882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral neurotoxicity of taxol in patients previously treated with cisplatin.
    Cavaletti G; Bogliun G; Marzorati L; Zincone A; Marzola M; Colombo N; Tredici G
    Cancer; 1995 Mar; 75(5):1141-50. PubMed ID: 7850713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue toxicity of cis-platinum in hyperthermic isolated extremity perfusion.
    Hild P; Aigner K; Schwemmle K; Henneking K; Illig L; Merker G; Hundeiker M; Paul E; Weber EG; Müller M
    Anticancer Res; 1982; 2(1-2):17-22. PubMed ID: 7202341
    [No Abstract]   [Full Text] [Related]  

  • 9. Regional perfusion with cis-platinum and dacarbazine.
    Aigner K; Hild P; Henneking K; Paul E; Hundeiker M
    Recent Results Cancer Res; 1983; 86():239-45. PubMed ID: 6685902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood changes in hyperthermic perfusion with chemotherapeutic preparations].
    Voronko EA; Fradkin SZ
    Vopr Onkol; 1974; 20(1):98. PubMed ID: 4216151
    [No Abstract]   [Full Text] [Related]  

  • 11. High plasma tumor necrosis factor (TNF)-alpha concentrations and a sepsis-like syndrome in patients undergoing hyperthermic isolated limb perfusion with recombinant TNF-alpha, interferon-gamma, and melphalan.
    Zwaveling JH; Maring JK; Clarke FL; van Ginkel RJ; Limburg PC; Hoekstra HJ; Koops HS; Girbes AR
    Crit Care Med; 1996 May; 24(5):765-70. PubMed ID: 8706451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotoxicity of isolated limb perfusion with tumor necrosis factor.
    Drory VE; Lev D; Groozman GB; Gutmann M; Klausner JM
    J Neurol Sci; 1998 Jun; 158(1):1-4. PubMed ID: 9667770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional hyperthermic perfusion with cisplatin following surgery for malignant melanoma of the extremities.
    Papa MZ; Klein E; Karni T; Koller M; Davidson B; Azizi E; Ben-Ari G
    Am J Surg; 1996 Apr; 171(4):416-20. PubMed ID: 8604833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperthermic isolated limb perfusion with cis-diamminedichloro-platinum. II. An experimental study in dogs with a balloon-occlusion technique for repeated high-dose treatment.
    Wessalowski R; Wilhelm M; Torsello S; Sager M; Güttler J; Jürgens H; Göbel U
    Med Pediatr Oncol; 1994; 22(6):393-7. PubMed ID: 8152401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperthermic regional perfusion in malignant melanoma of an extremity].
    Andersson AP; Drzewiecki KT
    Ugeskr Laeger; 1992 Oct; 154(41):2815-9. PubMed ID: 1413222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive evaluation of peripheral vasculature following regional hyperthermic chemotherapeutic perfusion (RHCP).
    Muchmore JH; Krementz ET; Kerstein MD
    Am Surg; 1987 Feb; 53(2):94-6. PubMed ID: 3544990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Technic of isolated perfusion of the extremities. Experience with 171 cases].
    Aigner K; Schwemmle K
    Langenbecks Arch Chir; 1983; 359(2):113-22. PubMed ID: 6681855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cis-Platinum-induced hypomagnesemia and peripheral neuropathy.
    Ashraf M; Scotchel PL; Krall JM; Flink EB
    Gynecol Oncol; 1983 Dec; 16(3):309-18. PubMed ID: 6317526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma.
    Möller MG; Lewis JM; Dessureault S; Zager JS
    Int J Hyperthermia; 2008 May; 24(3):275-89. PubMed ID: 18393005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cis-platinum-induced peripheral neuropathy. One case (author's transl)].
    Gastaut JL; Pellissier JF; Jean P; Tubiana N; Carcassonne Y
    Nouv Presse Med; 1982 Apr; 11(15):1113-7. PubMed ID: 6281722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.